Public Reporting
Identification of ACO participant(s)
- Crayton Ciborowski, MD
- Cross Roads Health Center, PLLC
- Jason N. Peet, MD, PA
- Wagner & Wagner, PA
- Family Practice Associates, PA
- Franklin Clinic, LP
- Jorge Diaz, MD
- South Austin Family Practice Clinic, LLP
- The Vaz Clinic, PA
- Wagner Medical Clinic, LLP
*No participants are involved in a joint venture between ACO professionals and hospitals
Del Norte ACO Address and Location
Del Norte ACO, LLC
El Paso, TX
ACO Primary Contact:
-
- Luis Urrea, M.D.
- President of ACO
- luisurrea@sbcglobal.net
- (915) 241-1214
-
- Crystal Ecton
- Innovista Health Solutions
- cecton@innovista-health.com
- (512) 663-8972
Identification of the Members of the ACO Governing Body
-
- O. Martin Franklin, DO, Co-President – Franklin Clinic, LP
- Tim Wagner, MD-Medical Director – Wagner & Wagner, PA
- Marshall Bishop, MD, Treasurer/ Co-Compliance Officer – Wagner Medical Clinic, LLP
- John D. Davis, MD, Co-Treasurer – Family Practice Associates, PA
- David R. Sprouse, MD, Secretary/Compliance Officer – Family Practice Associates, PA
- Garth O. Vaz, MD, Co-President – The Vaz Clinic, PA
- Jorge Duchicela, MD, – Youens, Duchicela & Associates, PA
- David Gumper Medicare Co-Rep
- Dennis Glenewinkel, MBA Medicare Co-Rep
- Kevin Spencer, MD – South Austin Family Practice Clinic, LLP
- Gurneet Kohli, MD – South Austin Family Practice Clinic, LLP
- David Gabriel, MD – South Austin Family Practice Clinic, LLP
Identification of the Types of ACO Participants or Combinations of Participants that Formed the ACO:
Alliance ACO LLC is a Texas, Limited Liability Company comprised of networks of individual practices of ACO professionals.
Amount of Shared Savings/Losses
Performance Year 1 2016: $0 Savings
Performance Year 2 2017: $3,269,673.00 Savings
How Shared Savings are distributed
Reinvestment in the ACO Infrastructure – 75%
Includes rewarding ACO providers and suppliers, as well as development of complex case management, care coordination, analytics, redesigning care processes, and physician education.
Rewarding Quality and Cost-efficient Care of the ACO Participants – 25%
Used to reward physician quality outcomes, beneficiary satisfaction, and financial efficiency in the management of care.
For general questions or additional information about Accountable Care Organizations, please visit www.medicare.gov/acos.html or call 1-800-MEDICARE (1-800-633-4227) TTY users should call 1-877-486-2048.
Quality Performance Results
Measure Number | Performance Measure | 2016 Reporting Period | 2017 Reporting Period | 2018 Reporting Period | |||
ACO Performance Rate | Mean Performance Rate for all ACOs | ACO Performance Rate | Mean Performance Rate for all ACOs | ACO Performance Rate | Mean Performance Rate for all ACOs | ||
ACO #1 | Getting Timely Care, Appointments, and Information | 80.64% | 80.51% | 80.57% | 80.60% | Current Year | Current Year |
ACO#2 | How Well Your Doctors Communicate | 92.66% | 93.01% | 92.49% | 93.13% | Current Year | Current Year |
ACO #3 | Patients’ Rating of Doctor | 91.93% | 92.25% | 92.35% | 92.31% | Current Year | Current Year |
ACO #4 | Access to Specialists | 86.91% | 83.49% | 85.12% | 83.32% | Current Year | Current Year |
ACO #5 | Health Promotion and Education | 56.53% | 60.32% | 61.58% | 62.30% | Current Year | Current Year |
ACO #6 | Shared Decision Making | 77.04% | 75.40% | 77.23% | 75.85% | Current Year | Current Year |
ACO #7 | Health Status/Functional Status | 70.53% | 72.30% | 72.72% | 73.05% | Current Year | Current Year |
ACO #8 | Risk Standardized, All Condition Readmissions | 14.48% | 14.70% | 14.86% | 15.1% | Current Year | Current Year |
ACO #9 | ASC Admissions: COPD or Asthma in Older Adults | 9.22% | 9.27% | Final Results Not Calculated | Final Results Not Calculated | Current Year | Current Year |
ACO #10 | ASC Admission: Heart Failure | 11.30% | 14.53% | Final Results Not Calculated | Final Results Not Calculated | Current Year | Current Year |
ACO #11 | Percent of PCPs who Qualified for EHR Incentive Payment | 35.71% | 75.15% | 100% | 82.72% | Current Year | Current Year |
ACO #12 | Medication Reconciliation | N/A | N/A | 92.04% | 75.32% | Current Year | Current Year |
ACO #13 | Falls: Screening for Fall Risk | 36.69% | 64.04% | 66.86% | 74.38% | Current Year | Current Year |
ACO #14 | Influenza Immunization | 70.56% | 68.32% | 74.72% | 72.52% | Current Year | Current Year |
ACO #15 | Pneumococcal Vaccination | 70.16% | 69.21% | 85.23% | 72.92% | Current Year | Current Year |
ACO #16 | Adult Weight Screening and Follow-up | 70.97% | 74.45% | 86.33% | 70.69% | Current Year | Current Year |
ACO #17 | Tobacco Use Assessment and Cessation Intervention | 89.11% | 90.98% | 95.95% | 90.48% | Current Year | Current Year |
ACO #18 | Depression Screening | 38.31% | 53.63% | 68.68% | 61.98% | Current Year | Current Year |
ACO #19 | Colorectal Cancer Screening | 58.47% | 61.52% | 77.50% | 64.58% | Current Year | Current Year |
ACO #20 | Mammography Screening | 64.61% | 67.61% | 72.73% | 70.05% | Current Year | Current Year |
ACO #21 | Proportion of Adults who had blood pressure screened in past 2 years | 85.48% | 76.79% | Final Results Not Calculated | Final Results Not Calculated | Current Year | Current Year |
ACO #22 | Hemoglobin A1c Control (HbA1c) (<8 percent) ACO #23 Low Density Lipoprotein (LDL) (<100 mg/dL) ACO #24 Blood Pressure (BP) <140/90 | N/A | N/A | Final Results Not Calculated | Final Results Not Calculated | Current Year | Current Year |
ACO #23 | Low Density Lipoprotein (LDL) (<100 mg/dL) | N/A | N/A | Final Results Not Calculated | Final Results Not Calculated | Current Year | Current Year |
ACO #24 | Blood Pressure (BP) <140/90 | N/A | N/A | Final Results Not Calculated | Final Results Not Calculated | Current Year | Current Year |
ACO #25 | Tobacco Non Use | N/A | N/A | Final Results Not Calculated | Final Results Not Calculated | Current Year | Current Year |
ACO #26 | Aspirin Use | N/A | N/A | Final Results Not Calculated | Final Results Not Calculated | Current Year | Current Year |
ACO #27 | Percent of beneficiaries with diabetes whose HbA1c in poor control (>9 percent) | 17.74% | 18.24% | 11.22% | 16.74% | Current Year | Current Year |
ACO #28 | Percent of beneficiaries with hypertension whose BP <140/90 | 69.40% | 70.69% | 72.69% | 71.47% | Current Year | Current Year |
ACO #29 | Percent of beneficiaries with IVD with complete lipid profile and LDL control <100mg/dl | N/A | N/A | Final Results Not Calculated | Final Results Not Calculated | Current Year | Current Year |
ACO #30 | Percent of beneficiaries with IVD who use Aspirin or other antithrombotic | 88.71% | 85.05% | 85.16% | 86.86% | Current Year | Current Year |
ACO #31 | Beta-Blocker Therapy for LVSD | 93.83% | 88.67% | Final Results Not Calculated | Final Results Not Calculated | Current Year | Current Year |
ACO #32 | Drug Therapy for Lowering LDL Cholesterol | N/A | N/A | Final Results Not Calculated | Final Results Not Calculated | Current Year | Current Year |
ACO #33 | ACE Inhibitor or ARB Therapy for Patients with CAD and Diabetes and/or LVSD | 78.07% | 79.67% | Final Results Not Calculated | Final Results Not Calculated | Current Year | Current Year |
ACO #34 | CAHPS: Stewardship of Patient Resources | 28.44% | 26.97% | 29.59% | 25.68% | Current Year | Current Year |
ACO #35 | Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM) | 19.41% | 18.17% | 18.52% | 18.46% | Current Year | Current Year |
ACO #36 | All-Cause Unplanned Admissions for Patients with Diabetes | 52.49% | 53.20% | 58.15% | 53.95% | Current Year | Current Year |
ACO #37 | All-Cause Unplanned Admissions for Patients with Heart Failure | 75.88% | 75.23% | 78.29% | 79.16% | Current Year | Current Year |
ACO #38 | All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions | 60.83% | 59.81% | 63.52% | 61.74% | Current Year | Current Year |
ACO #39 | Documentation of Current Medications in the Medical Record | 93.75% | 87.54% | Final Results Not Calculated | Final Results Not Calculated | Current Year | Current Year |
ACO #40 | Depression Remission at Twelve Months | 0% | 6.40% | 6.25% | 7.93% | Current Year | Current Year |
ACO #41 | Diabetes: Eye Exam | 26.61% | 44.94% | 51.60% | 50.37% | Current Year | Current Year |
ACO #42 | Statin therapy for the Prevention and Treatment of Cardiovascular Disease | 77.24% | 77.72% | 78.24% | 79.89% | Current Year | Current Year |
ACO #43 | Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91)) | – | – | 1.91% | 1.93% | Current Year | Current Year |
ACO #44 | Imaging Studies for Low Back Pain | – | – | 65.22% | 67.32% | Current Year | Current Year |